Evidence map›Paper›PMID 28138242›Full record

ArticleInternational journal of nanomedicine2017

Transient loading of CD34

Sarah Deville, Wahyu Wijaya Hadiwikarta, Nick Smisdom, Bart Wathiong, Marcel Ameloot, Inge Nelissen, Jef Hooyberghs

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sarah DevilleVITO, Flemish Institute for Technological Research, Mol, Belgium; Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Wahyu Wijaya HadiwikartaVITO, Flemish Institute for Technological Research, Mol, Belgium.
Nick SmisdomVITO, Flemish Institute for Technological Research, Mol, Belgium; Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Bart WathiongVITO, Flemish Institute for Technological Research, Mol, Belgium; Theoretical Physics, Hasselt University, Diepenbeek, Belgium.
Marcel AmelootBiomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
Inge NelissenVITO, Flemish Institute for Technological Research, Mol, Belgium.
Jef HooyberghsVITO, Flemish Institute for Technological Research, Mol, Belgium; Theoretical Physics, Hasselt University, Diepenbeek, Belgium.
Flemish Institute for Technological Research · BEHasselt University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD34

Indexed as

Antigens, CD34Bacterial ProteinsCell DeathCell ProliferationCells, CulturedGreen Fluorescent ProteinsHematopoietic Stem CellsHumansInfant, NewbornKineticsLuminescent ProteinsModels, BiologicalNanoparticlesPolystyrenesAntigens, CD34Bacterial ProteinsGreen Fluorescent ProteinsLuminescent ProteinsPolystyrenesyellow fluorescent protein, Bacteriadendritic cellshematopoietic progenitor cellsnanoparticlesreleaseuptake

Identifiers

PMID28138242
PMCPMC5238761
OpenAlexW2564642683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.